237 related articles for article (PubMed ID: 17258710)
1. Plasma alpha-synuclein is decreased in subjects with Parkinson's disease.
Li QX; Mok SS; Laughton KM; McLean CA; Cappai R; Masters CL; Culvenor JG; Horne MK
Exp Neurol; 2007 Apr; 204(2):583-8. PubMed ID: 17258710
[TBL] [Abstract][Full Text] [Related]
2. Platelet alpha- and gamma-synucleins in Parkinson's disease and normal control subjects.
Li QX; Campbell BC; McLean CA; Thyagarajan D; Gai WP; Kapsa RM; Beyreuther K; Masters CL; Culvenor JG
J Alzheimers Dis; 2002 Aug; 4(4):309-15. PubMed ID: 12446933
[TBL] [Abstract][Full Text] [Related]
3. Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment.
Duran R; Barrero FJ; Morales B; Luna JD; Ramirez M; Vives F
Mov Disord; 2010 Mar; 25(4):489-93. PubMed ID: 20063406
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects.
Bloch A; Probst A; Bissig H; Adams H; Tolnay M
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):284-95. PubMed ID: 16640647
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.
Foulds PG; Mitchell JD; Parker A; Turner R; Green G; Diggle P; Hasegawa M; Taylor M; Mann D; Allsop D
FASEB J; 2011 Dec; 25(12):4127-37. PubMed ID: 21865317
[TBL] [Abstract][Full Text] [Related]
6. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.
El-Agnaf OM; Salem SA; Paleologou KE; Curran MD; Gibson MJ; Court JA; Schlossmacher MG; Allsop D
FASEB J; 2006 Mar; 20(3):419-25. PubMed ID: 16507759
[TBL] [Abstract][Full Text] [Related]
7. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
8. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
Chiba-Falek O; Lopez GJ; Nussbaum RL
Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
[TBL] [Abstract][Full Text] [Related]
9. alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy.
Shults CW; Barrett JM; Fontaine D
Neurosci Lett; 2006 Sep; 405(3):223-5. PubMed ID: 16901642
[TBL] [Abstract][Full Text] [Related]
10. Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease.
Tokuda T; Salem SA; Allsop D; Mizuno T; Nakagawa M; Qureshi MM; Locascio JJ; Schlossmacher MG; El-Agnaf OM
Biochem Biophys Res Commun; 2006 Oct; 349(1):162-6. PubMed ID: 16930553
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
[TBL] [Abstract][Full Text] [Related]
12. [Frequency of the IVS4+66A-G polymorphism in the alpha-synuclein gene in patients with Parkinson's disease in north-western Mexico].
Ramírez-Jirano LJ; Ruiz-Sandoval JL; Jiménez-Gil FJ; Ramírez-Vega J; Vargas-Frutos E; Gallegos-Arreola MP
Rev Neurol; 2007 Jan 1-15; 44(1):15-7. PubMed ID: 17199224
[TBL] [Abstract][Full Text] [Related]
13. Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material.
Westerlund M; Belin AC; Anvret A; Håkansson A; Nissbrandt H; Lind C; Sydow O; Olson L; Galter D
FASEB J; 2008 Oct; 22(10):3509-14. PubMed ID: 18606870
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.
El-Agnaf OM; Salem SA; Paleologou KE; Cooper LJ; Fullwood NJ; Gibson MJ; Curran MD; Court JA; Mann DM; Ikeda S; Cookson MR; Hardy J; Allsop D
FASEB J; 2003 Oct; 17(13):1945-7. PubMed ID: 14519670
[TBL] [Abstract][Full Text] [Related]
15. Decreased activities of lysosomal acid alpha-D-galactosidase A in the leukocytes of sporadic Parkinson's disease.
Wu G; Yan B; Wang X; Feng X; Zhang A; Xu X; Dong H
J Neurol Sci; 2008 Aug; 271(1-2):168-73. PubMed ID: 18495164
[TBL] [Abstract][Full Text] [Related]
16. Determination of alpha-synuclein concentration in human plasma using ELISA.
Fjorback AW; Varming K; Jensen PH
Scand J Clin Lab Invest; 2007; 67(4):431-5. PubMed ID: 17558898
[TBL] [Abstract][Full Text] [Related]
17. α-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients.
Paslawski W; Zareba-Paslawska J; Zhang X; Hölzl K; Wadensten H; Shariatgorji M; Janelidze S; Hansson O; Forsgren L; Andrén PE; Svenningsson P
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15226-15235. PubMed ID: 31270237
[TBL] [Abstract][Full Text] [Related]
18. Sensitive and specific detection of α-synuclein in human plasma.
Tinsley RB; Kotschet K; Modesto D; Ng H; Wang Y; Nagley P; Shaw G; Horne MK
J Neurosci Res; 2010 Sep; 88(12):2693-700. PubMed ID: 20648655
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson's disease.
Salehi Z; Mashayekhi F
J Clin Neurosci; 2009 Jan; 16(1):90-3. PubMed ID: 19017558
[TBL] [Abstract][Full Text] [Related]
20. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
Wang X; Yu S; Li F; Feng T
Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
